SS Innovations Announces Chief Financial Officer Transition
SS Innovations International (NASDAQ: SSII), a surgical robotics technology company, has announced a planned CFO transition. Arvind Palaniappan has been appointed as Interim CFO effective May 1, 2025, replacing Anup Sethi, who served as CFO during the company's growth phase. Under Sethi's seven-year tenure, the company successfully launched over 80 surgical robotic systems in India and internationally, and recently achieved a milestone with its Nasdaq uplisting on April 25. The company has initiated a search for a permanent CFO, while Sethi will remain available in an advisory capacity during the transition period.
SS Innovations International (NASDAQ: SSII), un'azienda specializzata in tecnologia robotica chirurgica, ha annunciato una transizione pianificata del CFO. Arvind Palaniappan è stato nominato CFO ad interim a partire dal 1° maggio 2025, sostituendo Anup Sethi, che ha ricoperto il ruolo di CFO durante la fase di crescita dell'azienda. Durante i sette anni di mandato di Sethi, la società ha lanciato con successo oltre 80 sistemi robotici chirurgici in India e a livello internazionale, raggiungendo recentemente un importante traguardo con il listing al Nasdaq il 25 aprile. L'azienda ha avviato la ricerca di un CFO permanente, mentre Sethi resterà disponibile in qualità di consulente durante il periodo di transizione.
SS Innovations International (NASDAQ: SSII), una empresa de tecnología en robótica quirúrgica, ha anunciado una transición planificada en su CFO. Arvind Palaniappan ha sido nombrado CFO interino a partir del 1 de mayo de 2025, reemplazando a Anup Sethi, quien desempeñó el cargo durante la fase de crecimiento de la compañía. Durante los siete años de gestión de Sethi, la empresa lanzó con éxito más de 80 sistemas robóticos quirúrgicos en India y a nivel internacional, y recientemente alcanzó un hito con su listado en Nasdaq el 25 de abril. La compañía ha iniciado la búsqueda de un CFO permanente, mientras que Sethi permanecerá disponible en calidad de asesor durante el período de transición.
SS Innovations International (NASDAQ: SSII)는 외과용 로봇 기술 회사로, CFO 교체 계획을 발표했습니다. Arvind Palaniappan이 2025년 5월 1일부터 임시 CFO로 임명되어 회사 성장기 동안 CFO를 맡았던 Anup Sethi를 대신합니다. Sethi는 7년간 재임하는 동안 인도 및 국제적으로 80대 이상의 외과용 로봇 시스템을 성공적으로 출시했으며, 최근 4월 25일 나스닥 상장이라는 중요한 이정표를 달성했습니다. 회사는 영구 CFO를 찾기 위한 절차를 시작했으며, Sethi는 전환 기간 동안 자문 역할로 남을 예정입니다.
SS Innovations International (NASDAQ: SSII), une entreprise spécialisée dans la technologie de la robotique chirurgicale, a annoncé une transition prévue à la tête de sa direction financière. Arvind Palaniappan a été nommé directeur financier par intérim à compter du 1er mai 2025, remplaçant Anup Sethi, qui a occupé ce poste durant la phase de croissance de l'entreprise. Pendant les sept années de mandat de Sethi, la société a lancé avec succès plus de 80 systèmes robotiques chirurgicaux en Inde et à l'international, et a récemment franchi une étape importante avec son introduction au Nasdaq le 25 avril. L'entreprise a lancé une recherche pour un directeur financier permanent, tandis que Sethi restera disponible en tant que conseiller pendant la période de transition.
SS Innovations International (NASDAQ: SSII), ein Unternehmen für chirurgische Robotiktechnologie, hat einen geplanten CFO-Wechsel angekündigt. Arvind Palaniappan wurde zum Interim-CFO mit Wirkung zum 1. Mai 2025 ernannt und ersetzt Anup Sethi, der während der Wachstumsphase des Unternehmens als CFO tätig war. Während Sethis siebenjähriger Amtszeit brachte das Unternehmen erfolgreich über 80 chirurgische Robotersysteme in Indien und international auf den Markt und erreichte kürzlich einen Meilenstein mit dem Nasdaq-Listing am 25. April. Das Unternehmen hat die Suche nach einem dauerhaften CFO eingeleitet, während Sethi während der Übergangszeit beratend zur Verfügung stehen wird.
- Company successfully launched over 80 surgical robotic systems in India and overseas
- Recently achieved Nasdaq uplisting milestone
- Seamless transition planned with departing CFO remaining as advisor
- New interim CFO brings extensive financial and operations experience
- Uncertainty during transitional period until permanent CFO is appointed
- Loss of experienced CFO who guided company through growth phase and public listing
FORT LAUDERDALE, Fla., May 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company’s Interim Chief Financial Officer, effective May 1, 2025, pursuant to a planned leadership transition. Anup Sethi, SS Innovations’ departing CFO, will remain available to advise the Company prior to the appointment of a permanent CFO. SS Innovations has commenced a search process to identify and recruit a permanent successor for the CFO role.
Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “We are pleased to appoint Arvind as the Interim CFO of SS Innovations. He is a seasoned financial and operations executive who brings us a wealth of accounting and financial management experience and expertise. We are confident in a seamless transition of responsibilities.”
Dr. Srivastava continued, “On behalf of the Board of Directors and executive team, I want to thank Anup for his financial leadership and many contributions to SS Innovations over the past seven years, including most recently in the role of CFO. He helped build strong accounting and finance functions that drove the growth of our business, supported the launch of more than 80 surgical robotic systems in India and overseas, and allowed us to transition from a high growth start up to a publicly-traded company. We mutually agreed that the milestone of the uplisting of our common stock to Nasdaq on April 25 provided an opportune time to commence the CFO transition. We are grateful that Anup has agreed to be an advisor during this transition period and wish him all the best in his next endeavors.”
About Mr. Palaniappan
Mr. Palaniappan is a Chartered Accountant with the Institute of Chartered Accountants, England and Wales with over 30 years of experience in accounting and financial management, risk and controls consulting, assurance and compliance and global business outsourcing process delivery. Since February 2020, he has been the principal of Trogon Consulting, a private consulting firm providing outsourced chief financial officer and risk management services to private and public clients. From 2006 to 2020, he occupied a number of executive positions, including Managing Director (Senior Operations Executive) for Accenture Solutions in India, where he provided various financial, management and operational oversight services with respect to Accenture Solutions, Indian delivery centers. His prior affiliations include Axis Consulting Services (part of the Ambit – RSM Group) in Bangalore, Intel Technologies India in Bangalore and Arthur Andersen in New Delhi. Mr. Palaniappan holds Bachelors and Masters of Commerce degrees from The Madras Christian College.
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of surgical procedures including robotic cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra Surgical Robotic System is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.
Forward Looking Statements
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations International’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Investor Contact:
The Equity Group
Kalle Ahl, CFA
T: (303) 953-9878
kahl@equityny.com
Devin Sullivan, Managing Director
T: (212) 836-9608
dsullivan@equityny.com
Media Contact:
press@ssinnovations.org
T: (212) 739-0300
FAQ
Who is the new interim CFO of SS Innovations (SSII)?
Why is SS Innovations (SSII) changing its CFO?
How many surgical robotic systems has SS Innovations (SSII) launched?
When did SS Innovations (SSII) uplist to Nasdaq?
What happens to the former CFO of SS Innovations (SSII)?
